Turenne Capital logo

Turenne Capital

Europe, Ile-de-France, France, Paris

Description

Turenne Capital is a private equity management and venture capital company.

Investor Profile

Turenne Capital has made 53 investments, with 3 in the past 12 months and 26% as lead.

Stage Focus

  • Series Unknown (38%)
  • Series A (25%)
  • Private Equity (15%)
  • Series B (13%)
  • Seed (6%)
  • Series C (4%)

Country Focus

  • France (91%)
  • Germany (6%)
  • United States (2%)
  • Poland (2%)

Industry Focus

  • Software
  • Biotechnology
  • Health Care
  • Medical
  • Internet
  • Information Technology
  • E-commerce
  • Manufacturing
  • Medical Device
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Turenne Capital frequently co-invest with?

Omnes Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 4
XAnge
Europe, Ile-de-France, France, Paris
Co-Investments: 3
ACG Management
Europe, Provence-Alpes-Cote d'Azur, France, Marseille
Co-Investments: 2
Région Sud Investissement
Europe, Provence-Alpes-Cote d'Azur, France, Marseille
Co-Investments: 2
Paca Investissement
Europe, Ile-de-France, France, Paris
Co-Investments: 5
Kurma Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 4
IRDI SORIDEC Gestion
Europe, Midi-Pyrenees, France, Toulouse
Co-Investments: 2
CTI Life Sciences Fund
North America, Quebec, Canada, Montréal
Co-Investments: 2
BNP Paribas Développement
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Bpifrance
Europe, Ile-de-France, France, Maisons-alfort
Co-Investments: 7

Which angels does Turenne Capital often collaborate with?

CR
Europe, Geneve, Switzerland, Geneva
Shared Deals: 1
TE
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Shared Deals: 1

What are some of recent deals done by Turenne Capital?

Germitec SAS

Ivry-sur-seine, Ile-de-France, France

Germitec is a healthcare company that designs, Commercialize UV-C disinfection systems for hospital hygiene system.

Health CareMedical
Series BFeb 12, 2025
Amount Raised: $30,043,719
Coave Therapeutics

Paris, Ile-de-France, France

Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.

BiotechnologyGeneticsLife ScienceNeuroscience
Series AJan 9, 2025
Amount Raised: $32,948,556
Sydev

Échirolles, Rhone-Alpes, France

Sydev is a publisher of management software and tariff databases for technical building trades in the construction industry.

ComputerConstructionSoftware
Series UnknownSep 27, 2024
Amount Raised: $11,059,784
Antabio

Labège, Midi-Pyrenees, France

Antabio is a private biopharmaceutical company developing antibacterial resistance-breakers in areas of highest medical need.

BiotechnologyLife ScienceMedical Device
Series BDec 12, 2023
Amount Raised: $26,996,237
AlgoTherapeutix

Suresnes, Ile-de-France, France

AlgoTherapeutix is the operator of a biotechnology company designed to develop topical treatments for complex pain.

BiotechnologyInformation TechnologyPharmaceutical
Series BMar 14, 2023
Amount Raised: $21,453,404
Amolyt Pharma

Écully, Rhone-Alpes, France

Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders.

BiotechnologyHealth CareMedicalPharmaceuticalWellness
Series CJan 6, 2023
Amount Raised: $138,629,699
Tradim

Paris, Ile-de-France, France

Tradim offers integrated software and hardware for waste collection management and treatment.

HardwareSoftwareSoftware EngineeringWaste Management
Series UnknownOct 13, 2022
Amount Raised: $19,534,760
Domain Therapeutics

Illkirch, Alsace, France

Domain Therapeutics develops small molecules targeting G-coupled protein receptors.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series AMay 10, 2022
Amount Raised: $41,063,697
PathoQuest

Paris, Ile-de-France, France

PathoQuest is a biotech company developing NGS-based metagenomic tests for exhaustive identification of pathogens.

BiotechnologyHealth CareTherapeutics
Series BNov 9, 2021
Amount Raised: $17,391,748
AI Verse

Sophia Antipolis, Provence-Alpes-Cote d'Azur, France

AI Verse offers a self-service image factory that produces high-quality labeled synthetic datasets for training Computer Vision applications

Artificial Intelligence (AI)Machine Learning
SeedSep 1, 2021
Amount Raised: $2,960,374